Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in J Am Soc Nephrol

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    May 2018
  1. ILATOVSKAYA DV, Blass G, Palygin O, Levchenko V, et al
    A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2018 May 23. pii: ASN.2018030280. doi: 10.1681/ASN.2018030280.
    PubMed     Text format     Abstract available


    April 2018
  2. HICKSON LJ, Balls-Berry JE, Jaffe AS, Rule AD, et al
    Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women?
    J Am Soc Nephrol. 2018 Apr 20. pii: ASN.2017121249. doi: 10.1681/ASN.2017121249.
    PubMed     Text format    


  3. MA X, Schwarz A, Sevilla SZ, Levin A, et al
    Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.
    J Am Soc Nephrol. 2018 Apr 10. pii: ASN.2017101135. doi: 10.1681/ASN.2017101135.
    PubMed     Text format     Abstract available


    March 2018
  4. ZHONG F, Chen H, Xie Y, Azeloglu EU, et al
    Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    J Am Soc Nephrol. 2018 Mar 6. pii: ASN.2017030234. doi: 10.1681/ASN.2017030234.
    PubMed     Text format     Abstract available


    February 2018
  5. BRENNAN EP, Mohan M, McClelland A, Tikellis C, et al
    Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.
    J Am Soc Nephrol. 2018 Feb 28. pii: ASN.2017101112. doi: 10.1681/ASN.2017101112.
    PubMed     Text format     Abstract available


    January 2018
  6. KIM Y, Lim JH, Kim MY, Kim EN, et al
    The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    J Am Soc Nephrol. 2018 Jan 12. pii: ASN.2017060627. doi: 10.1681/ASN.2017060627.
    PubMed     Text format     Abstract available


    November 2017
  7. MOTTL AK, Gasim A, Schober FP, Hu Y, et al
    Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD.
    J Am Soc Nephrol. 2017 Nov 27. pii: ASN.2017020192. doi: 10.1681/ASN.2017020192.
    PubMed     Text format     Abstract available


    October 2017
  8. WANG XX, Wang D, Luo Y, Myakala K, et al
    FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    J Am Soc Nephrol. 2017 Oct 31. pii: ASN.2017020222. doi: 10.1681/ASN.2017020222.
    PubMed     Text format     Abstract available


  9. HARLAN SM, Heinz-Taheny KM, Sullivan JM, Wei T, et al
    Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
    J Am Soc Nephrol. 2017 Oct 23. pii: ASN.2017040385. doi: 10.1681/ASN.2017040385.
    PubMed     Text format     Abstract available


  10. HINDEN L, Udi S, Drori A, Gammal A, et al
    Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    J Am Soc Nephrol. 2017 Oct 13. pii: ASN.2017040371. doi: 10.1681/ASN.2017040371.
    PubMed     Text format     Abstract available


    September 2017
  11. LIU Y, Li H, Liu J, Han P, et al
    Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
    J Am Soc Nephrol. 2017 Sep 18. pii: ASN.2015091017. doi: 10.1681/ASN.2015091017.
    PubMed     Text format     Abstract available


    July 2017
  12. ZHANG MZ, Wang X, Yang H, Fogo AB, et al
    Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.
    J Am Soc Nephrol. 2017 Jul 24. pii: ASN.2017010107. doi: 10.1681/ASN.2017010107.
    PubMed     Text format     Abstract available


  13. MARQUARDT A, Al-Dabet MM, Ghosh S, Kohli S, et al
    Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy.
    J Am Soc Nephrol. 2017 Jul 10. pii: ASN.2016101123. doi: 10.1681/ASN.2016101123.
    PubMed     Text format     Abstract available


    May 2017
  14. COCA SG, Nadkarni GN, Huang Y, Moledina DG, et al
    Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
    J Am Soc Nephrol. 2017 May 5. pii: ASN.2016101101. doi: 10.1681/ASN.2016101101.
    PubMed     Text format     Abstract available


  15. NEUMILLER JJ, Alicic RZ, Tuttle KR
    Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2017 May 2. pii: ASN.2016121372. doi: 10.1681/ASN.2016121372.
    PubMed     Text format     Abstract available


    February 2017
  16. VAN JA, Scholey JW, Konvalinka A
    Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.
    J Am Soc Nephrol. 2017 Feb 3. pii: ASN.2016091018. doi: 10.1681/ASN.2016091018.
    PubMed     Text format     Abstract available


    January 2017
  17. TONNEIJCK L, Muskiet MH, Smits MM, van Bommel EJ, et al
    Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.
    J Am Soc Nephrol. 2017 Jan 31. pii: ASN.2016060666. doi: 10.1681/ASN.2016060666.
    PubMed     Text format     Abstract available


    November 2016
  18. MA RC, Cooper ME
    Genetics of Diabetic Kidney Disease-From the Worst of Nightmares to the Light of Dawn?
    J Am Soc Nephrol. 2016 Nov 23. pii: ASN.2016091028.
    PubMed     Text format    


    September 2016
  19. VOELKER J, Berg PH, Sheetz M, Duffin K, et al
    Anti-TGF-beta1 Antibody Therapy in Patients with Diabetic Nephropathy.
    J Am Soc Nephrol. 2016 Sep 19. pii: ASN.2015111230.
    PubMed     Text format     Abstract available


  20. SANDHOLM N, Van Zuydam N, Ahlqvist E, Juliusdottir T, et al
    The Genetic Landscape of Renal Complications in Type 1 Diabetes.
    J Am Soc Nephrol. 2016 Sep 19. pii: ASN.2016020231.
    PubMed     Text format     Abstract available


  21. RECIO C, Lazaro I, Oguiza A, Lopez-Sanz L, et al
    Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.
    J Am Soc Nephrol. 2016 Sep 8. pii: ASN.2016020237.
    PubMed     Text format     Abstract available


    August 2016
  22. DE BOER IH, Kahn SE
    SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?
    J Am Soc Nephrol. 2016 Aug 18. pii: ASN.2016060650.
    PubMed     Text format    


    July 2016
  23. MORI KP, Yokoi H, Kasahara M, Imamaki H, et al
    Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy.
    J Am Soc Nephrol. 2016 Jul 6. pii: ASN.2015101168.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: